Surgical Site Infection After Posterolateral Lumbar Fusion: Incidence and Risk Factors in a Nationwide Database
Background: Posterolateral lumbar fusion (PLF) is a widely performed procedure for degenerative lumbar spine disease, yet postoperative surgical site infection (SSI) remains a consequential complication. The aim of this study was to estimate the national 90-day incidence of SSI following PLF and identify independent predictors of 90-day SSI. Materials and Methods: We performed a retrospective cohort study of adults undergoing PLF in the PearlDiver Mariner database from 2016 to 2023. Multivariable logistic regression identified independent predictors of 90-day SSI, adjusting for demographic, procedural, and comorbidity variables. Significance was set at P < .001. Results: Among 291,435 PLF procedures, 14,725 (5.1%) developed a 90-day SSI. SSI occurred in 4.0% (6,105/151,951) of single-level PLF cases and 6.2% (8,620/139,484) of multilevel cases. Multilevel fusion significantly increased infection risk compared with single-level PLF (odds ratio [OR] 1.47, P < .001). Independent predictors included obesity (OR 1.60, P < .001), anemia (OR 1.70, P < .001), fluid and electrolyte disorders (OR 1.59, P < .001), essential hypertension (OR 1.34, P < .001), congestive heart failure (OR 1.22, P < .001), depression (OR 1.21, P < .001), diabetes (OR 1.15, P < .001), cardiac arrhythmias (OR 1.21, P < .001), coagulopathy/hemorrhagic disorders (OR 1.18, P < .001), substance-related disorders (OR 1.18, P < .001), peripheral vascular disease (OR 1.17, P < .001), and tobacco use (OR 1.11, P < .001). Conclusion: Ninety-day SSI after PLF was more frequent following multilevel fusion and among patients with substantial cardiometabolic, hematologic, and behavioral comorbidities.
Authors
- Gregory Douglas Schroeder (ORCID: https://orcid.org/0000-0002-8895-1964)
- Alexander Richard Vaccaro (ORCID: https://orcid.org/0000-0002-8073-0796)
- Arie Monas (ORCID: https://orcid.org/0009-0008-4886-1535)
- Christopher K. Kepler (ORCID: https://orcid.org/0000-0002-0996-4346)
- Khaled Abdelmoneim Elmenawi (ORCID: https://orcid.org/0000-0003-1801-960X)
- Jad Bou Monsef (ORCID: https://orcid.org/0000-0001-5614-3690)
- Jorden L. Xavier (ORCID: https://orcid.org/0000-0001-5770-0292)
- Mitchell K. Ng (ORCID: https://orcid.org/0000-0002-5831-055X)
- Luke B. Schwartz (ORCID: https://orcid.org/0000-0003-4506-1993)
- Afshin E. Razi (ORCID: https://orcid.org/0000-0002-3443-4582)
- Pemla Jagtiani (ORCID: https://orcid.org/0000-0002-6075-0255)
- Paul G. Mastrokostas (ORCID: https://orcid.org/0000-0002-1196-517X)
- Leonidas E. Mastrokostas (ORCID: https://orcid.org/0009-0006-8926-3502)
- Arya G. Varthi (ORCID: https://orcid.org/0000-0003-4508-8598)
- Rajendra Singh
- John K. Houten (ORCID: https://orcid.org/0000-0002-4295-9434)
- Mohamed Said (ORCID: https://orcid.org/0000-0002-3884-6269)
- Masataka Mizuno
Institutions
- Cleveland Clinic (US)
- Yale New Haven Hospital (US)
- Maimonides Medical Center (US)
- SUNY Downstate Health Sciences University (US)
- Thomas Jefferson University Hospital (US)
- Cleveland Foundation (US)
- Rothman Orthopaedics (US)
- Cooper University Health Care (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Orthopedics
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3928/01477447-20261030-01
- Primary Topic
- Surgical site infection prevention
- Type
- article
- Field-Weighted Citation Impact
- 0.00